Abstract
Carcinoma of Gall bladder is an infrequent tumour of the gastrointestinal tract and has long been recognized as a highly lethal disease. Tumour markers are glycoprotein that can be determined in blood, saliva, urine and tissues by certain immunological methods. Cyclin D1 is such a marker which is seen to be expressed in various neoplasms. Its role has also been confirmed in gall bladder neoplastic conditions. The onset and progression of gallbladder carcinoma are accompanied with multiple genetic changes that result in qualitative and quantitative alterations in individual gene expression. Immuno-histochemical methods can be used to analyze cyclin D1 levels in gallbladder carcinomas, adenomas and cholecystitis to evaluate their relationships with the pathogenesis, development and metastasis of gallbladder carcinoma.
Highlights
AND REVIEW With the increase in cases of neoplasm, both primary and recurrent worldwide there lies importance of aid which will provide both sensitive and specific diagnosis and prognosis of the condition
Cyclin D1 is such a marker which is seen to be expressed in various neoplasms
Its role has been confirmed in gall bladder neoplastic conditions
Summary
AND REVIEW With the increase in cases of neoplasm, both primary and recurrent worldwide there lies importance of aid which will provide both sensitive and specific diagnosis and prognosis of the condition. Tumour markers are glycoprotein that can be determined in blood, saliva, urine and tissues by certain immunological methods. Certain studies have confirmed their role in progression of tumour and in poor prognosis.
Sign-in/Register to view highlights & summary Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
